The final pre-print of the IBDverse project is out now ✨ - looking at the genetics of IBD 🧬 Led by the amazing @tobioinformatics.bsky.social and @bradleyomics.bsky.social

🚨 SUPER EXCITED to share our new preprint on the mucosal and circulatory immune landscape of Crohn’s disease! 🩸 Blood is commonly used in biomarker discovery and drug development, but how well does it reflect what's actually happening in the gut? 👀 🧵 1/10 🔗 www.medrxiv.org/content/10.1...

All these measures will not only affect US-based science but worldwide (eg. developing countries). Guess so much about equity in genomics? Hopefully, other (maybe non-US) alternatives arise from this 🙏🏻

New paper alert 📢! (Cell) @cp-cell.bsky.social - How does immune responses to solid tumors vary by age and tumor characteristics in children?! www.cell.com/cell/fulltex... 🧵1/8

"Women full professors are 19% more likely than men at the same career stage to leave academia, as compared with 6% for women assistant professors and 10% for associates."

This is really horrific. These single cell reference atlases are widely used as is to train all kinds of models! This is one of the reasons I've constantly harping about uniform reprocessing & extremely careful QC of large atlases. 1/

Today, I got the opportunity to present at #ISCBLA2024 about how we are using single-cell to identify circulating and tissue specific signatures in Crohn's disease 👩🏻‍💻

Hi everyone! Here's a starter pack of genomics scientists trained in Mexico 🇲🇽 including from #LCG-UNAM #LCG-EJ-UNAM undergrads, #RMB / #NNB-UNAM / @cdsbmexico.bsky.social workshops, and more It's in an early stage and I'm trying to get more to join us here at #AcademicSky go.bsky.app/5bWBN5V